Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?

Source:http://linkedlifedata.com/resource/pubmed/id/18487581

J. Clin. Oncol. 2008 May 20 26 15 2600; author reply 2601-2

Download in:

View as

Triples

General Info

PMID
18487581